CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 50 enrolled
Drug / intervention
BENZOYL PEROXIDE/ CLINDAMYCIN +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00887484
NCT00887484Phase 4Completed

A Single-blind, Randomized, Comparative Pilot Study Evaluating the Tolerability of Two Topical Combination Therapies in the Treatment of Acne Vulgaris

Stiefel, a GSK Company·interventional·Posted Apr 24, 2009·Updated Dec 13, 2016

In Brief

A Phase 4 clinical trial evaluating BENZOYL PEROXIDE/ CLINDAMYCIN and BENZOYL PEROXIDE/ ADAPALENE for Acne Vulgaris. Completed, enrolled 50 participants across 4 sites.

Detailed Summary

The purpose of this study is to compare the tolerability of topical combination therapies in the treatment of facial acne.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesArgentina
CollaboratorsGlaxoSmithKline

Timeline

Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 24, 2009
Enrollment StartFeb 1, 2009
Primary CompletionJun 1, 2009
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 17.2 years ago

Interventions

BENZOYL PEROXIDE/ CLINDAMYCINdrug

Commencing at baseline, subjects will apply once daily both treatment arm #1 and treatment arm #2 in a bilateral split-face fashion (allocation to left and right side randomly assigned) for an initial 2 weeks. At 2 weeks, subjects will apply benzoyl peroxide/clindamycin gel to the entire face for an additional 6 weeks.

BENZOYL PEROXIDE/ ADAPALENEdrug

Commencing at baseline, subjects will apply once daily both treatment arm #1 and treatment arm #2 in a bilateral split-face fashion (allocation to left and right side randomly assigned) for an initial 2 weeks. At 2 weeks, subjects will apply benzoyl peroxide/clindamycin gel to the entire face for an additional 6 weeks.